Precision medicine in oncology has allowed major therapeutic breakthroughs, using molecular profiles to tailor treatment options. Tremendous benefits for the patient have been observed in some cancer types. Nevertheless, precision medicine has profoundly modified the role of the patient, the oncologist and the general practitioner in the healthcare circuit. Practical and technical issues also arise from the generation of the molecular profiles, which consist of large files that need to be stored and protected. In this path, we will discuss the impact advances in the post-genomic era have on the patient and civil society, the subsequent big data challenges, and changes in paradigms in the way patients are treated.
Here are the key questions to be debated: